Engdologix (ELGX) CFO Buys 150K Shares
More News related to ELGX
- Endologix (ELGX) Reports Powerlink XL Trial Met Primary Endpoint
- Endologix Announces Favorable Powerlink XL Clinical Trial Results
- Endologix Responds to Unsolicited Proposal from Elliott Associates
- Favorable Endologix Powerlink XL System Clinical Data to Be Announced November 20 at Veith Symposium
- Endologix to Present at the Stephens Fall Investment Conference
Engdologix (Nasdaq: ELGX) CFO, John Krist purchased 150,000 shares on 8/14-8/15 at prices ranging from $2.42-$2.45, bringing his stake to 226,899 shares.
Endologix, Inc. engages in the development, manufacture, sale, and marketing of minimally invasive therapies for the treatment of vascular diseases.
Related Categories
Insider TradesStocks Mentioned
+0.00Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
